Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Hematocrit ChangeCardiovascular PreventionEmpagliflozinSGLT2-InhibitorsTissue Oxygenation

Interventions

DRUG

Empagliflozin10Mg Tab

TB JARDIANCE 10MG

Trial Locations (1)

RECRUITING

Papageorgiou General Hospital, Thessaloniki

All Listed Sponsors

lead

Aristotle University Of Thessaloniki

OTHER